NIAGEN BIOSCIENCE, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NIAGEN BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $2.77M.
- NIAGEN BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $2.35M.
- NIAGEN BIOSCIENCE, INC. treasury stock, value, acquired, cost method for fiscal 2025 was $251.00K.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $2.77M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.35M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $251.00K 10-K · filed 2026-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |